期刊文献+

阿托伐他汀对大鼠肾脏缺血再灌注损伤的影响 被引量:1

Protective effects of atorvastatin on ischemical reperfusion injury of kidney in rats
下载PDF
导出
摘要 目的:探讨不同剂量阿托伐他汀预处理对大鼠肾脏缺血再灌注损伤的影响。方法:健康成年雄性SD大鼠72只,随机分为6组(n=12):假手术组(S组);缺血再灌注组(IR组);阳性对照硝苯地平预处理组(N组);阿托伐他汀低、中和高剂量预处理组(AL组、AM组和AH组)。再灌注24h,检测大鼠血清尿素氮(BUN)和肌酐(Cr)水平,丙二醛(MDA)含量和超氧物歧化酶(SOD)活性,观察肾组织形态学改变。结果:与S组比较,其余五组血清BUN和Cr水平、MDA含量升高,SOD活性降低(P<0.05),肾组织有不同程度的病理学损伤。与IR组比较,AL组、AM组和AH组血清BUN和Cr水平、MDA含量降低,SOD活性升高(P<0.05),肾组织病理学损伤减轻,但AL组、AM组和AH组之间差异无统计学意义(P>0.05)。结论:阿托伐他汀预处理对大鼠肾脏缺血再灌注损伤有明显保护作用,其机制可能与抑制脂质过氧化反应有关。 To discuss protective effects of different doses of atorvastatin on ischemical reperfusion injury of kidney in rats. Methods: 72 healthy adult male SD rats were randomly divided into 6 groups (n=12): sham operation group(group S); ischemia reperfusion group(group IR); nifedipine pretreatment group(group N); low, medium and high doses of atorvastatin pretreatment group(group AL, group AM and group AH). With reperfusion for 24 hours, the level of BUN, Cr, MDA and SOD activity was detected, and pathological changes in kidney tissues were observed. Results:Compared with group S, the level of BUN, Cr and MDA was significantly higher (P〈0.05), and the SOD activities was obviously lower in other groups(P〈0.05). Compared with group IR, the level of BUN, Cr and MDA was obviously lower (P〈0.05), the SOD activities was significantly higher, and the pathological changes were reduced in AL, AM and AH groups (P〈0.05), but there was no significant difference in three groups (P〉0.05). Conclusion:There were significant protective effects of atorvastatin pretreatment in ischemical reperfusion injury of kidney in rats, which may be related to the inhibiting lipid peroxidation.
出处 《中医临床研究》 2014年第20期123-125,共3页 Clinical Journal Of Chinese Medicine
基金 河南省教育厅自然科学研究项目(12B310009)
关键词 阿托伐他汀 肾脏缺血再灌注 MDA SOD Atorvastatin Renal ischemia reperfusion MDA SOD
  • 相关文献

参考文献9

二级参考文献55

  • 1陈聪聪,柳子明,王慧华,孙菊妹,邬伟东.乌司他丁对大鼠肾缺血/再灌注损伤的保护作用[J].中华麻醉学杂志,2004,24(11):828-832. 被引量:23
  • 2杨虹,魏桂荣,李红戈.脑梗死血清MMP-3与MMP-9的动态变化及临床意义[J].中国康复,2005,20(5):278-280. 被引量:12
  • 3Shi-Qiang Shen,Yuan Zhang,Jin-Jian Xiang,Cheng-Long Xiong.Protective effect of curcumin against liver warm ischemia/reperfusion injury in rat model is associated with regulation of heat shock protein and antioxidant enzymes[J].World Journal of Gastroenterology,2007,13(13):1953-1961. 被引量:34
  • 4Yu CM ,Zhang Q ,Lam L,et al. Comparison of intensive and low-doso atorvastatin therapy in the reduction of carotid intimal-medial thickness in patients with coronary heart disease [ J ]. Heart, 2007,93 ( 8 ) :933 -939.
  • 5Azar RR, Sarkis A, Salameh E, et al. Percutaneous coronary intervention increases leptin and decreases adiponectin levels [ J ]. Clin Endocrinol(Oxf) ,2006,65 (6) :712-716.
  • 6Chyrchel M, Rakowski T, Rzeszutko L, et al. Effects of high-dose statin administered prior to coronary angioplasty on the incidence of cardiac events in patients with acute coronary syndrome[ J]. Kardiol Pol,2006,64(12) :1357-1362.
  • 7Patti G, Pasceri V, Colonna G, et al. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention:results of the ARMYDA-ACS randomized trial[ J ]. J Am Coll Cardiol,2007,49(12) : 1272-1278.
  • 8Uden JA, Ray JG. Primary and secondary prevention of heart failure with statins [J]. Expert Rev Cardiovasc Ther,2006,4(6) :917-926.
  • 9Tousoulis D,Charakida M,Stefanadi E,et al. Statins in heart failure,beyond the lipid lowering effect [ J ]. Int J Cardiol,2007,115 (2) : 144-150.
  • 10Sola S, Mir MQ, Lerakis S, et al. Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure[ J]. J Am Coll Cardiol, 2006,47 ( 2 ) : 332-337.

共引文献35

同被引文献9

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部